Latest news with #COMET
CBS News
14 hours ago
- CBS News
Cocaine, methamphetamine confiscated after search warrants served in Downriver area
Suspected shooter captured in Minnesota; death investigation in Bedford Township; and more top stori Suspected shooter captured in Minnesota; death investigation in Bedford Township; and more top stori Over ½ kilogram of cocaine and more than 3,000 methamphetamine pills were among the items confiscated during a series of police searches in Metro Detroit's Downriver area. The County of Macomb Enforcement Team (COMET) led the investigation, according to the report from Michigan State Police. Assisting agencies included Metro Narcotics Enforcement Team, Michigan State Police's Second District, Taylor Police Department and the Federal Bureau of Investigation. Items that were confiscated during search warrants June 13, 2025, in Metro Detroit's Downriver region. Michigan State Police During the multiple search warrants served Friday, detectives seized over 1/2 kilogram of cocaine, more than 3,000 methamphetamine pills, Fentanyl, Hydrocodone, Alprazolam, 13 firearms, and over $6,000 with intent to forfeit. The investigation was supported by the Edward Byrne Memorial Justice Assistance (JAG) grant program, which is awarded by the Bureau of Justice Assistance, Office of Justice Programs and U.S. Department of Justice; then administered by the Michigan State Police.
CBS News
16-05-2025
- CBS News
Detroit man faces multiple drugs, weapon charges in narcotics investigation
A Detroit man was charged in a Metro Detroit narcotics investigation that resulted in the seizure of over 10,000 pills. Justin Shannon Alexander, 35, had an arraignment hearing Friday in 36th District Court on multiple charges that include delivery of controlled substance, firearms possession by a felony, ammunition possession by a felon and felony firearms, the Michigan State Police, Metro Detroit district reported. Bond was set at $50,000 cash surety. The investigation was led by the County of Macomb Enforcement Team, known as COMET. The street value of the confiscated drugs was about $50,000; officers also seized 12 firearms and $35,000 in cash.
Yahoo
31-03-2025
- Business
- Yahoo
Bio-Techne Opens New Customer Experience Centre in Germany
Bio-Techne Corporation TECH recently opened a new Customer Experience Centre in Düsseldorf, Germany, to serve customers across the Europe, Middle East and Africa ('EMEA') region. The facility's capacity should enable the company to grow its customer-centric team in the EMEA and support long-term regional growth. The new Customer Experience Centre is scheduled to be opened in the first half of 2026. The facility will complement the company's existing Demonstration Laboratory in the United Kingdom. Düsseldorf was chosen as the site for this new center due to its thriving life sciences sector and strategic proximity to the Benelux region, providing seamless access to customers from multiple European markets. The facility will feature a state-of-the-art Demonstration Laboratory hosting Bio-Techne's full instrument portfolio, including the recently launched Leo System, powered by Simple Western Technology, which offers the throughput and precision of standard ELISAs in a fully automated western blot assay. It will also host the best-in-class spatial biology platform COMET, which is the only fully automated, high-throughput, hyperplex platform with superior tissue profiling capabilities. Per a report by BioSpace, the life science market is projected to witness a compound annual growth rate (CAGR) of 10.28% from 2024 to 2033. This robust growth is driven by technological advancements, growing demand for personalized medicine, and increasing investments in research and development. Earlier this month, Asuragen — a Bio-Techne brand — partnerd with Oxford Nanopore Technologies to launch the AmplideX Nanopore Carrier Plus Kit. The research-use-only AmplideX Nanopore Carrier Plus Kit is a new genetic panel that will support software analysis for carrier screening research. Last month, the company expanded its menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation therapeutics and diagnostics. Designed to deliver spatial precision with advanced sensitivity and specificity, the Advanced Cell Diagnostics ('ACD') branded RNAscope probe portfolio now covers more than 70,000 unique probes across over 450 species. In the life sciences research space, Bio-Techne faces competition from some prominent MedTech players. These companies are also making notable developments in their respective businesses. QIAGEN N.V. QGEN, one of Bio-techne's major competitors, recently announced a significant enhancement in the capabilities of its QIAcuity dPCR system, with a more than two-fold increase in the number of targets that can be simultaneously analyzed from a single biological sample. Additionally, QIAGEN partnered with Genomics England to support the delivery of the 100,000 Genomes Project, also known as the Generation Study. This first-of-its-kind initiative is aimed to sequence the genomes of 100,000 newborns in England, to screen over 200 selected conditions, enabling earlier diagnosis and treatment of rare conditions. Another competitor of Bio-Techne is Thermo Fisher Scientific TMO. In January, the company's Olink Explore Platform was selected by UK Biobank Pharma Proteomics Project (UKB-PPP) to support the world's largest human proteomics study of its kind. UKB-PPP aims to analyze more than 5,400 proteins from 600,000 samples to fuel the discovery of new protein biomarkers that can be used to predict, diagnose and treat diseases. Additionally, in 2024, the company introduced new additions to the Gibco CTS Detachable Dynabeads platform to further enhance the development and manufacturing of life-changing cell therapies. Another competitor is Bio-Rad BIO, which made several advancements in 2024 to further expand the ddPCR platform into life science research and clinical diagnostics. For instance, the company invested in Geneoscopy to support the launch of its FDA-approved, non-invasive colorectal cancer screening test, powered by the ddPCR platform. According to the latest update, Bio-Rad's QX600 Droplet Digital PCR (ddPCR) platform is currently robust and continues to grow. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report QIAGEN N.V. (QGEN) : Free Stock Analysis Report Bio-Rad Laboratories, Inc. (BIO) : Free Stock Analysis Report Bio-Techne Corp (TECH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
South China Morning Post
11-03-2025
- Business
- South China Morning Post
ByteDance says new AI technology boosts model training efficiency by 1.7 times
TikTok owner ByteDance said it has achieved a 1.71 times efficiency improvement in large language model (LLM) training, the latest Chinese tech company to achieve a breakthrough that could potentially reduce demand for Nvidia's high-end graphics processing units (GPUs). Advertisement The company's Doubao development team said they managed to 'speed up' LLM training efficiency by '1.71 times' through COMET, an optimised Mixture-of-Experts (MoE) system, according to a recent paper published on arXiv, an online forum for professionals in the scientific community. MoE is a machine learning technique where multiple expert networks are used to divide a problem space into homogeneous sections. The technique has been extensively adopted to scale LLMs to trillion-plus parameters, while maintaining fixed computing cost. It is widely adopted by leading artificial intelligence (AI) models such as Grok and DeepSeek. The headquarters of ByteDance is seen in Beijing on September 16, 2020. Photo: AFP The new system has already been adopted in the company's production environment of clusters using over 10,000 GPUs, achieving 'savings of millions of GPU hours', according to the Doubao team. Breakthroughs in reducing the training cost for AI models could lead to lower demand for chips from Nvidia, whose high-performance GPUs are subject to strict export controls by the US. The rise of Hangzhou-based DeepSeek, which developed and trained its AI models at a fraction of the cost and with fewer computing resources than its Western counterparts, had led to speculation that demand for Nvidia GPUs could slow. After the DeepSeek breakthrough, Nvidia experienced a nearly US$600 billion drop in market value last month, in the largest single-day drop for any US company, before it rebounded the next day. Advertisement Although widely adopted by major tech companies, the MoE technique leads to so-called 'communication-computation overlapping', which 'introduces a notable impairment of computational efficiency', according to the ByteDance scientists. The new system is aimed at addressing this problem by 'eliminating fine-grained communication bottlenecks and enhancing its adaptability across various scenarios', they wrote.
